Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2025

Authors

  • Monica M Lahra NSW Health Pathology, World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, Microbiology, Prince of Wales Hospital, Randwick, NSW 2031, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW 2052, Australia
  • Siobhan M Hurley NSW Health Pathology, World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, Microbiology, Prince of Wales Hospital, Randwick, NSW 2031, Australia
  • Tiffany R Hogan NSW Health Pathology, World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, Microbiology, Prince of Wales Hospital, Randwick, NSW 2031, Australia

DOI:

https://doi.org/10.33321/cdi.2026.50.027

Keywords:

antimicrobial resistance, disease surveillance, invasive meningococcal disease, Neisseria meningitidis

Abstract

The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and molecular based techniques.

Data contained in quarterly reports are restricted to a description of case numbers of IMD by jurisdiction and serogroup, where known and expanded in 2024 to include antimicrobial resistance data for ceftriaxone, penicillin, ciprofloxacin and rifampicin. A full analysis of laboratory confirmations of IMD in each calendar year are contained in the AMSP annual reports.

Downloads

Download data is not yet available.

References

Australian Centre for Disease Control (Australian CDC), Communicable Diseases Network Australia (CDNA). Invasive Meningococcal Disease: CDNA National Guidelines for Public Health Units. Canberra: Australian CDC; 4 July 2017. Available from: https://www.cdc.gov.au/resources/publications/invasive-meningococcal-disease-cdna-national-guidelines-public-health-units.

Lahra MM, Hogan TR. Australian Meningococcal Surveillance Programme Annual Report, 2019. Commun Dis Intell (2018). 2020:44. doi: https://doi.org/10.33321/cdi.2020.44.62.

Lahra MM, Hogan TR. Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2025. Commun Dis Intell (2018). 2025;49. doi: https://doi.org/10.33321/cdi.2025.49.045.

Lahra MM, George RCR, van Hal SJ, Hogan TR. Australian Meningococcal Surveillance Programme Annual Report, 2022. Commun Dis Intell (2018). 2023:47. doi: https://doi.org/10.33321/cdi.2023.47.44.

Light blue curved shape with the words Communicable Diseases Intelligence in dark blue. Celebrating Volume 50 of Communicable Diseases Intelligence in 2026. Colourful fireworks and stars make up the shape of the zero in 50. The bottom of the cover features dark blue and light blue shapes with a lockup of the logo of the Australian Centre for Disease Control alongside the Commonwealth Coat of Arms.

Downloads

Published

16/06/26

How to Cite

Lahra, Monica, Siobhan Hurley, and Tiffany Hogan. 2026. “Meningococcal Surveillance Australia: Reporting Period 1 July to 30 September 2025”. Communicable Diseases Intelligence 50 (June). https://doi.org/10.33321/cdi.2026.50.027.

Issue

Vol. 50 (2026)

Section

Recently published

Categories

License

Copyright (c) 2026 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.